| 摘要 |
The present invention provides a method of treating a disease or a disord er responsive to inhibition of nuclear factor-kB transcription factors comprisi ng administering to a patient in need thereof a sulfonylaminocarbonyl derivativ e, or a pharmaceutically acceptable salt thereof. The methods of the present inventi on are useful for treating, for example, rheumatoid arthritis, osteoarthritis, an autoimmune disease, psoriasis, asthma, a cardiovascular disease, an acute coronary syndrome, congestive heart failure, Alzheimer's disease, multiple sclerosis, cancer, type II diabetes, metabolic syndrome X, or inflammatory bowel disease.
|
